GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that ...

Please provide your email address to receive an email when new articles are posted on . The FDA has cleared the Eversense 365 CGM for adults with type 1 or type 2 diabetes. The system includes an ...

Between school, extracurriculars, and social obligations, a young person’s life is already busy. But adding type 1 diabetes management on top of that can feel like an overwhelming load for the patient ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments. Objectives: Advances in diabetes technology have led to ...